Immune cell combo shows promise in tough brain cancer trial
NCT ID NCT00807027
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 28 times
Summary
This study tested whether adding an immune cell therapy called Immuncell-LC to standard chemotherapy (temozolomide) helps people with newly diagnosed glioblastoma, an aggressive brain cancer. 180 adults in Korea took part. The goal was to see if the combination improved how long the cancer stayed under control and overall survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Gyunghee University Medical Center
Seoul, South Korea
-
Hanyang University Guri Hospital
Guri-si, Gyeonggi-do, South Korea
-
Konkuk University
Seoul, South Korea
-
Korea University Anam Hospital
Seoul, South Korea
-
Samsung Seoul Medical Center
Seoul, South Korea
-
Seoul Asan Medical Center
Seoul, South Korea
-
Yeonsei University Medical Center
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.